Nasdaq Edges Higher; Neovasc Shares Jump
U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite turning higher on Tuesday.
Why Calyxt Shares Are Trading Higher By Around 116%? Here Are Other Stocks Moving In Tuesday’s Mid-Day Session
Gainers
Celyad Oncology SA (NASDAQ: CYAD) jumped 187% to $2.30 after gaining 21% on Friday. Celyad Oncology, last month, decided to discontinue the development of its remaining clinical program CYAD-211.
Edesa Biotech’s Dermatitis Study Data Fails To Cheer Investors
Edesa Biotech Inc (NASDAQ:EDSA) announced preliminary topline results from a Phase 2b study evaluating multiple concentrations of the company’s drug candidate,…
Dow Tumbles 300 Points; Morgan Stanley Beats Q4 Views
U.S. stocks traded mostly lower midway through trading, with the Dow Jones dropping over 300 points on Tuesday.
Why AMC Entertainment Shares Are Trading Lower By Around 13%? Here Are 59 Stocks Moving In Thursday’s Mid-Day Session
Gainers
Core Scientific, Inc. (NASDAQ: CORZ) shares jumped 188% to $0.1471. Core Scientific shares dipped 75% on Wednesday after the company filed for Chapter 11 bankruptcy.
Stocks That Hit 52-Week Lows On Thursday
During Thursday's session, 97 companies made new 52-week lows.
Why F45 Training Shares Climbed 41%; Here Are 84 Biggest Movers From Friday
Gainers
FingerMotion, Inc. (NASDAQ: FNGR) gained 82.2% to close at $3.37.
Edesa Biotech Reports Statistically Significant Mortality Reductions In Phase 2 ARDS Drug Study; Says ‘EB05 demonstrated an 84% reduction in the risk of dying when compared to placebo’
Mortality reduction in critically ill subjects at 28 days revised favorably, statistically significant
EB05 demonstrated an 84% reduction in the risk of dying when compared to placebo
Clinical Study Report
Zacks Small-Cap Research Sets $15 Valuation On Edesa Biotech
Zacks_SCR_Research_08242022_EDSA_Bautz.pdf (q4cdn.com)
